Dr. Tatiana Segura's lab at Duke University focuses on developing innovative biomaterials to aid recovery after ischemic stroke. By utilizing extracellular vesicles from activated astrocytes, the lab explores new therapies that promote brain repair and regeneration instead of merely protecting against damage. The ultimate goal is to create effective treatments that target the underlying issues of stroke-related disabilities, offering new hope for patients.

Dr. Jonathan Viventi's lab at Duke University focuses on developing advanced technology to help patients with severe speech impairments, such as those caused by ALS or Locked-in Syndrome. The main goal is to create a wireless device that can capture brain signals and translate them into speech, allowing these individuals to communicate more effectively. By using high-density micro-electrocorticographic arrays and machine learning algorithms, the lab aims to transform how technology assists with verbal communication for those who need it most.

The lab led by Dr. Benjamin Wildman-Tobriner focuses on improving the management of thyroid nodules using advanced imaging techniques and artificial intelligence. The main goal of the research is to reduce unnecessary biopsies and treatments for low-risk thyroid cancers by developing criteria that emphasize patient outcomes rather than merely diagnosing cancer. By integrating machine learning with ultrasound imaging, the lab aims to enhance diagnostic accuracy and ultimately lower healthcare costs.

Dr. George Truskey's research lab focuses on understanding and developing therapies for Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic disorder that causes rapid aging in children. The lab utilizes in vitro models of human blood vessels made from induced pluripotent stem cells to study the disease's effects on vascular function and to explore potential genetic therapies using advanced gene editing techniques. This research aims to improve the treatment of HGPS and other rare diseases that lack sufficient patients for clinical trials.

The research lab focuses on developing advanced diagnostic tools for early detection of head and neck cancers, especially in low-resource settings. They aim to create portable, easy-to-use devices that utilize novel nanotechnology to quickly identify cancer markers, improving outcomes for underserved communities. By integrating cutting-edge techniques in molecular analysis, the lab's work is designed to provide faster and more accurate cancer diagnostics, ultimately saving lives.